Britain's Native Antigen Company introduces novel coronavirus antigens
Share:
PARIS (Reuters) - British-based The Native Antigen Company said on Wednesday that it had introduced novel antigens to deal with the coronavirus afflicting China."The Native Antigen Company, one of the world's leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial introduction of its Novel Coronavirus antigens, derived from the emerging Wuhan strain," it said in a statement."These recombinant..